Get the Stockscreener App
5.125
4.38%
0.215
After Hours:
5.13
0.005
+0.10%
Cara Therapeutics Inc Stock (CARA) Forecast
The Cara Therapeutics Inc (CARA) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $2.2761, representing a -55.59% decrease from the current price of $5.125. The highest analyst price target is $3.8867, and the lowest is $0.6655.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CARA Price Target
Average 3.2112
(-37.34% Downside)
Is Cara Therapeutics Inc (CARA) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 55.83 | Neutral |
| STOCH(9,6) | 55.98 | Neutral |
| STOCHRSI(14) | 100.00 | Sell |
| MACD(12,26) | -0.0174 | Buy |
| ADX(14) | 16.06 | Neutral |
| William %R | -8.3333 | Sell |
| CCI(14) | 69.76 | Neutral |
Buy: 1
Sell: 2
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
4.7965
Buy
|
4.8778
Buy
|
| MA20 |
4.9668
Buy
|
4.9001
Buy
|
| MA50 |
4.965
Buy
|
4.7815
Buy
|
| MA100 |
4.281
Buy
|
4.6208
Buy
|
| MA200 |
4.3531
Buy
|
5.3285
Sell
|
Buy: 9
Sell: 1
Neutral: 0
Summary: Buy
According to our latest analysis, CARA could be considered a Strong Buy, with 17 technical analysis indicators signaling 10 Buy signals, 3 signaling Sell signals and 4 Neutral signals. This might be a good time to open fresh positions on CARA, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 55.83 indicates that CARA is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 55.98 indicates that CARA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that CARA is oversold. This suggests that CARA price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 16.06 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 69.76 indicates that CARA is still overbought but not to an extreme extent.
Long-term CARA price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Cara Therapeutics Inc financial reports and earnings history, Cara Therapeutics Inc (CARA) stock could reach $17.00 by 2030, $8.9659 by 2040 and $31.94 by 2050. See the projected annual prices until 2050 of the Cara Therapeutics Inc stock below:
- Cara Therapeutics Inc (CARA) is expected to reach an average price of $3.8002 in 2035, with a high prediction of $3.9519 and a low estimate of $3.8806. This indicates an $-25.85% rise from the last recorded price of $5.125.
- Cara Therapeutics Inc (CARA) stock is projected to chart a bullish course in 2040, with an average price target of $9.0296, representing an $76.19% surge from its current level. The forecast ranges from a conservative $9.1991 to a sky-high $8.9659.
- Our analysts predict Cara Therapeutics Inc (CARA) to jump 208.45% by 2045, soaring from $16.20 to an average price of $15.81, potentially reaching $16.05. While $16.20 is the low estimate, the potential upside is significant.
- Cara Therapeutics Inc (CARA) stock is expected to climb by 2050, reaching an average of $29.39, a $473.37% jump from its current level. However, a wide range of estimates exists, with high and low targets of $31.94 and $30.47, respectively, highlighting the market's uncertainty.
Cara Therapeutics Inc Stock (CARA) Year by Year Forecast
Cara Therapeutics Inc Stock (CARA) Price Forecast for 2025
Cara Therapeutics Inc Stock (CARA) is expected to reach an average price of $2.6473 in 2025, with a high prediction of $5.2828 and a low estimate of $0.0118. This indicates an -48.35% fall from the last recorded price of $5.125.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| April, 2025 | $2.2279 | $0.6655 | $3.8867 | -56.53% |
| May, 2025 | $0.0454 | $0.4004 | $2.0286 | -99.11% |
| June, 2025 | $0.3571 | $0.041 | $1.764 | -93.03% |
| July, 2025 | $2.244 | $0.314 | $2.3546 | -56.21% |
| August, 2025 | $3.4815 | $2.0034 | $3.8015 | -32.07% |
| September, 2025 | $3.0391 | $2.2397 | $4.7109 | -40.70% |
| October, 2025 | $1.626 | $1.14 | $5.2828 | -68.27% |
| November, 2025 | $0.6515 | $0.5259 | $2.3854 | -87.29% |
| December, 2025 | $0.1804 | $0.0123 | $2.091 | -96.48% |
Cara Therapeutics Inc Stock (CARA) Price Forecast for 2026
The predicted value for Cara Therapeutics Inc (CARA) in 2026 is set at an average of $9.2025. Estimates vary from a peak of $18.05 to a trough of $0.3527, indicating an +79.56% surge from the present price of $5.125.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $2.1079 | $0.3527 | $3.5186 | -58.87% |
| February, 2026 | $2.5155 | $1.7373 | $2.7802 | -50.92% |
| March, 2026 | $6.193 | $2.0748 | $6.4102 | +20.84% |
| April, 2026 | $7.9599 | $5.8718 | $10.47 | +55.32% |
| May, 2026 | $7.7974 | $4.8087 | $8.3493 | +52.14% |
| June, 2026 | $17.59 | $7.1668 | $18.05 | +243.32% |
| July, 2026 | $1.9019 | $0.5019 | $17.95 | -62.89% |
| August, 2026 | $2.8994 | $1.7212 | $3.1194 | -43.43% |
| September, 2026 | $3.1463 | $2.5459 | $4.0675 | -38.61% |
| October, 2026 | $2.2638 | $0.6938 | $3.3057 | -55.83% |
| November, 2026 | $5.4913 | $1.6332 | $7.902 | +7.15% |
| December, 2026 | $5.4383 | $4.1895 | $6.2583 | +6.11% |
Cara Therapeutics Inc Stock (CARA) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Cara Therapeutics Inc (CARA) is $4.6811, with a high forecast of $9.3539 and a low forecast of $0.00834. This indicates an -8.66% decrease from the last price of $5.125.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $2.9358 | $2.7308 | $5.5426 | -42.72% |
| February, 2027 | $4.6633 | $2.9852 | $9.3539 | -9.01% |
| March, 2027 | $3.2302 | $2.4002 | $4.9927 | -36.97% |
| April, 2027 | $2.9677 | $2.4584 | $3.9284 | -42.09% |
| May, 2027 | $1.9153 | $1.6553 | $3.6412 | -62.63% |
| June, 2027 | $2.2522 | $1.0634 | $3.4222 | -56.06% |
| July, 2027 | $3.9397 | $1.9916 | $4.4897 | -23.13% |
| August, 2027 | $4.1472 | $3.9591 | $5.9922 | -19.08% |
| September, 2027 | $0.5641 | $0.0941 | $4.2066 | -88.99% |
| October, 2027 | $0.6017 | $0.00834 | $1.6523 | -88.26% |
| November, 2027 | $2.5992 | $0.786 | $2.7392 | -49.28% |
| December, 2027 | $4.6061 | $1.1667 | $6.0761 | -10.12% |
Cara Therapeutics Inc Stock (CARA) Price Forecast for 2028
In 2028, Cara Therapeutics Inc (CARA) is projected to reach an average price of $3.6656, with a high projection of $7.3082 and a low estimate of $0.023. This indicates an -28.48% fall from the last price of $5.125.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $3.9736 | $3.5742 | $5.0055 | -22.47% |
| February, 2028 | $2.9311 | $1.8611 | $4.6729 | -42.81% |
| March, 2028 | $3.2681 | $2.3805 | $4.7393 | -36.23% |
| April, 2028 | $5.2956 | $2.5468 | $5.6562 | +3.33% |
| May, 2028 | $4.7025 | $4.6025 | $7.0837 | -8.24% |
| June, 2028 | $6.44 | $3.9819 | $6.49 | +25.66% |
| July, 2028 | $5.7575 | $5.7175 | $7.3082 | +12.34% |
| August, 2028 | $1.2344 | $1.1544 | $6.1369 | -75.91% |
| September, 2028 | $0.032 | $0.023 | $1.4238 | -99.38% |
| October, 2028 | $0.0395 | $0.3255 | $0.1399 | -99.23% |
| November, 2028 | $0.9636 | $0.381 | $0.7836 | -81.20% |
| December, 2028 | $0.9861 | $0.8148 | $0.6339 | -80.76% |
Cara Therapeutics Inc Stock (CARA) Price Forecast for 2029
The 2029 price forecast for Cara Therapeutics Inc Stock (CARA) is $8.1215 on average, with a high prediction of $16.18 and a low estimate of $0.0651. This represents an +58.47% increase from the previous price of $5.125.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.1892 | $0.2592 | $0.7673 | -96.31% |
| February, 2029 | $0.5016 | $0.441 | $0.281 | -90.21% |
| March, 2029 | $0.7041 | $0.6622 | $0.6435 | -86.26% |
| April, 2029 | $1.3866 | $1.3247 | $1.191 | -72.94% |
| May, 2029 | $1.4597 | $1.4291 | $1.3478 | -71.52% |
| June, 2029 | $1.2121 | $1.342 | $1.3115 | -76.35% |
| July, 2029 | $1.2916 | $1.0534 | $1.2346 | -74.80% |
| August, 2029 | $1.1721 | $1.1877 | $1.2565 | -77.13% |
| September, 2029 | $0.5931 | $0.8902 | $1.0883 | -88.43% |
| October, 2029 | $0.32 | $0.4027 | $0.4308 | -93.76% |
| November, 2029 | $0.3048 | $0.2745 | $0.1839 | -94.05% |
| December, 2029 | $17.43 | $0.0651 | $16.18 | +240.05% |
Cara Therapeutics Inc Stock (CARA) Price Forecast for 2030
Cara Therapeutics Inc Stock (CARA) is expected to reach an average price of $13.86 in 2030, with a high forecast of $19.16 and a low forecast of $8.5624. This signifies an +170.50% surge from the last price of $5.125.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $16.18 | $16.01 | $17.00 | +215.69% |
| February, 2030 | $11.06 | $13.82 | $14.95 | +115.78% |
| March, 2030 | $12.04 | $10.92 | $10.53 | +134.90% |
| April, 2030 | $10.93 | $11.55 | $10.84 | +113.25% |
| May, 2030 | $15.48 | $11.70 | $15.13 | +202.05% |
| June, 2030 | $13.23 | $14.15 | $14.09 | +158.24% |
| July, 2030 | $8.5911 | $11.78 | $12.47 | +67.63% |
| August, 2030 | $15.44 | $8.5624 | $15.03 | +201.19% |
| September, 2030 | $16.05 | $15.96 | $15.79 | +213.19% |
| October, 2030 | $13.50 | $14.00 | $15.02 | +163.36% |
| November, 2030 | $19.16 | $14.17 | $16.30 | +273.90% |
| December, 2030 | $17.45 | $18.11 | $19.16 | +240.43% |
2.14%
2.83%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):